These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7796583)
41. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth JD; Morrissey LH; Scullin DC; Houston GA; Prasthofer EF; Gray JR; Burris HA; Greco FA Cancer; 2002 May; 94(9):2426-33. PubMed ID: 12033195 [TBL] [Abstract][Full Text] [Related]
42. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229). Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558 [TBL] [Abstract][Full Text] [Related]
43. European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer. Ardizzoni A; Manegold C; Debruyne C; Gaafar R; Buchholz E; Smit EF; Lianes P; ten Velde G; Bosquee L; Legrand C; Neumaier C; King K; Clin Cancer Res; 2003 Jan; 9(1):143-50. PubMed ID: 12538462 [TBL] [Abstract][Full Text] [Related]
46. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group. Jett JR; Hatfield AK; Hillman S; Bauman MD; Mailliard JA; Kugler JW; Morton RF; Marks RS; Levitt R Cancer; 2003 May; 97(10):2498-503. PubMed ID: 12733149 [TBL] [Abstract][Full Text] [Related]
47. A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer. Tabata M; Kiura K; Okimoto N; Segawa Y; Shinkai T; Yonei T; Kuyama S; Harita S; Hotta K; Ueoka H; Tanimoto M Cancer Chemother Pharmacol; 2007 Jun; 60(1):1-6. PubMed ID: 17393168 [TBL] [Abstract][Full Text] [Related]
48. Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience. Hainsworth JD; Burris HA; Greco FA Semin Oncol; 2001 Apr; 28(2 Suppl 4):43-7. PubMed ID: 11479897 [TBL] [Abstract][Full Text] [Related]
49. A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500). Pandya KJ; Dahlberg S; Hidalgo M; Cohen RB; Lee MW; Schiller JH; Johnson DH; J Thorac Oncol; 2007 Nov; 2(11):1036-41. PubMed ID: 17975496 [TBL] [Abstract][Full Text] [Related]
50. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer. Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659 [TBL] [Abstract][Full Text] [Related]
52. Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials. Kosmidis PA; Samantas E; Fountzilas G; Pavlidis N; Apostolopoulou F; Skarlos D Semin Oncol; 1994 Jun; 21(3 Suppl 6):23-30. PubMed ID: 8052870 [TBL] [Abstract][Full Text] [Related]
53. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial. Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596 [TBL] [Abstract][Full Text] [Related]
54. Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. Choi HJ; Cho BC; Shin SJ; Cheon SH; Jung JY; Chang J; Kim SK; Sohn JH; Kim JH Cancer Chemother Pharmacol; 2008 Feb; 61(2):309-13. PubMed ID: 17576560 [TBL] [Abstract][Full Text] [Related]
55. Duration of accrual and follow-up for two-stage clinical trials. Case LD; Morgan TM Lifetime Data Anal; 2001 Mar; 7(1):21-37. PubMed ID: 11280845 [TBL] [Abstract][Full Text] [Related]
56. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587). Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185 [TBL] [Abstract][Full Text] [Related]
57. Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial. Oh IJ; Kim KS; Park CK; Kim YC; Lee KH; Jeong JH; Kim SY; Lee JE; Shin KC; Jang TW; Lee HK; Lee KY; Lee SY BMC Cancer; 2016 Aug; 16(1):690. PubMed ID: 27566413 [TBL] [Abstract][Full Text] [Related]
58. Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline. Cheng S; Evans WK; Stys-Norman D; Shepherd FA; J Thorac Oncol; 2007 Apr; 2(4):348-54. PubMed ID: 17409809 [TBL] [Abstract][Full Text] [Related]
59. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update. Ettinger DS Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538 [TBL] [Abstract][Full Text] [Related]
60. Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study. Schiller JH; Ettinger DS; Larson MM; Gradishar W; Merkel D; Johnson DH Eur J Cancer; 1994; 30A(2):158-61. PubMed ID: 8155389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]